Thirty-Day Mortality Rates in Patients with Extended-Spectrum ß-Lactamase-Producing <i>Enterobacterales</i> Bacteremia Receiving Ertapenem versus Other Carbapenems.

Park, Jin Ju; Jung, Eun-Ju; Kim, Jae-Young; Seo, Yu Bin; Lee, Jacob; Jung, Younghee

Thirty-Day Mortality Rates in Patients with Extended-Spectrum ß-Lactamase-Producing Enterobacterales Bacteremia Receiving Ertapenem versus Other Carbapenems.

Park, Jin Ju; Jung, Eun-Ju; Kim, Jae-Young; Seo, Yu Bin; Lee, Jacob; Jung, Younghee.

Afiliação

Park JJ; Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea.
Jung EJ; Dongtan Sacred Heart Hospital, College of Medicine, Hallym University, Hwaseong, South Korea.
Kim JY; Department of Statistics, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea.
Seo YB; Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea.
Lee J; Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea.
Jung Y; Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, South Korea.

Antimicrob Agents Chemother ; 66(7): e0028722, 2022 07 19.

Article em En | MEDLINE | ID: mdl-35708330

Assuntos

Bacteriemia; Carbapenêmicos; Antibacterianos/uso terapêutico; Bacteriemia/microbiologia; Carbapenêmicos/uso terapêutico; Ertapenem/uso terapêutico; Escherichia coli; Humanos; Klebsiella pneumoniae; Estudos Retrospectivos; beta-Lactamases

Palavras-chave

carbapenems; ertapenem; extended-spectrum ß-lactamase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Carbapenêmicos / Bacteriemia Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google